These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36888957)

  • 1. Telemonitoring of the Continuum of Care of Hepatitis C During the COVID-19 Pandemic in Brazil.
    Bittencourt PL; Codes L; César AMDG; Mussi FC; Ferraz MLG
    Telemed J E Health; 2023 Nov; 29(11):1673-1678. PubMed ID: 36888957
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
    Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of COVID-19 pandemic on the 2020 hepatitis C cascade of care in the Republic of Georgia.
    Gamkrelidze A; Handanagic S; Shadaker S; Turdziladze A; Tsereteli M; Getia V; Aslanikashvili A; Surguladze S; Gvinjilia L; Kuchuloria T; Tskhomelidze I; Armstrong PA
    Public Health; 2022 Apr; 205():182-186. PubMed ID: 35305459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrieval of HCV patients lost to follow-up as a strategy for Hepatitis C Microelimination: results of a Brazilian multicentre study.
    Ferraz MLG; de Andrade ARCF; Pereira GHS; Codes L; Bittencourt PL
    BMC Infect Dis; 2023 Jul; 23(1):468. PubMed ID: 37442976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study.
    Barocas JA; Savinkina A; Lodi S; Epstein RL; Bouton TC; Sperring H; Hsu HE; Jacobson KR; Schechter-Perkins EM; Linas BP; White LF
    Clin Infect Dis; 2022 Aug; 75(1):e1112-e1119. PubMed ID: 34499124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy.
    Cooper MP; Foley H; Damico D; Wright M; Rhudy C; Schadler A; Platt T
    J Manag Care Spec Pharm; 2022 Jun; 28(6):667-672. PubMed ID: 35621721
    [No Abstract]   [Full Text] [Related]  

  • 7. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic.
    Hartl L; Jachs M; Bauer D; Simbrunner B; Chromy D; Binter T; Steininger L; Schwarz C; Schwarz M; Burghart L; Strassl R; Trauner M; Gschwantler M; Mandorfer M; Reiberger T
    J Viral Hepat; 2022 Dec; 29(12):1062-1072. PubMed ID: 36062398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic.
    Tai CM; Bair MJ; Chen TH; Tseng CH; Chen CC; Lam H; Yu ML
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Hepatitis C Birth Cohort Screening and Linkage to Care in a US Community Health System.
    Zijlstra MK; Fidel Nague K; Louie P; Imas P; Sonnenberg A; Fimmel CJ
    J Public Health Manag Pract; 2022 Nov-Dec 01; 28(6):E825-E830. PubMed ID: 36194824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?
    Sowah L; Chiou C
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):585-588. PubMed ID: 33913731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Immunodeficiency Virus and Hepatitis C Linkage-to-Care Initiative for New Orleans Residents Experiencing Homelessness During the COVID-19 Pandemic.
    Cironi KA; Jones AT; Hauser EM; Olsen JW; Kissinger PJ
    Sex Transm Dis; 2021 Aug; 48(8):595-600. PubMed ID: 34030154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co-V2 pandemic.
    Huang CI; Liang PC; Wei YJ; Tsai PC; Hsu PY; Hsieh MY; Liu TW; Lin YH; Hsieh MH; Jang TY; Wang CW; Yang JF; Yeh ML; Huang CF; Dai CY; Chuang WL; Huang JF; Yu ML
    J Microbiol Immunol Infect; 2023 Jun; 56(3):586-597. PubMed ID: 37188573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuum of hepatitis C care in France: A 20-year cohort study.
    Hermetet C; Dubois F; Gaudy-Graffin C; Bacq Y; Royer B; Gaborit C; D'Alteroche L; Desenclos JC; Roingeard P; Grammatico-Guillon L
    PLoS One; 2017; 12(8):e0183232. PubMed ID: 28850623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA.
    Amele S; Peters L; Sluzhynska M; Yakovlev A; Scherrer A; Domingo P; Gerstoft J; Viard JP; Gisinger M; Flisiak R; Bhaghani S; Ristola M; Leen C; Jablonowska E; Wandeler G; Stellbrink H; Falconer K; D'Arminio Monforte A; Horban A; Rockstroh JK; Lundgren JD; Mocroft A;
    HIV Med; 2019 Apr; 20(4):264-273. PubMed ID: 30734998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study).
    Huang JF; Hsieh MY; Wei YJ; Hung JY; Huang HT; Huang CI; Yeh ML; Huang CF; Jang TY; Hsu PY; Liang PC; Dai CY; Lin ZY; Yu ML; Chuang WL
    Hepatol Int; 2022 Feb; 16(1):59-67. PubMed ID: 34850326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?
    do Carmo RF; de Souza CDF
    J Hepatol; 2022 Feb; 76(2):470-472. PubMed ID: 34437907
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia.
    Stvilia K; Vephkvadze N; Gamkrelidze A; Khonelidze I; Getia V; Tsereteli M; Gvinjilia L; Kuchuloria T
    Public Health; 2021 Jun; 195():42-50. PubMed ID: 34051674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.
    Carvalho-Louro DM; Soares EB; Trevizoli JE; Marra TMG; da Cunha ALR; Rodrigues MP; Carvalho-Furtado ACL; Dos Santos BTA; de Assis da Rocha Neves F
    BMC Infect Dis; 2020 Feb; 20(1):114. PubMed ID: 32041537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.